Journal of Pediatric Epilepsy 2018; 07(03): 103-105
DOI: 10.1055/s-0038-1676858
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Dravet Syndrome and Psychiatric Comorbidity

W. Boudewijn Gunning
1   Stichting Epilepsie Instellingen Nederland, Zwolle, The Netherlands
,
Lisette J.J.M. van Gemert
2   Epilepsy Center Kempenhaeghe, Heeze, The Netherlands
› Institutsangaben
Weitere Informationen

Publikationsverlauf

12. Mai 2018

19. November 2018

Publikationsdatum:
20. Dezember 2018 (online)

Abstract

This is a review of the prevalence of psychiatric comorbidity in patients with Dravet syndrome (DS) and the predictors of psychiatric comorbidity. Symptoms of attention-deficit hyperactivity disorder are most frequently reported in children with DS. Autistic features and “other behavior problems” are also found in a considerable proportion of children. No consistent relationship has been found with intellectual disability level, age of onset of seizures, delay in diagnosis, and seizure frequency. A major limitation of the literature is that formal psychiatric assessment has rarely been applied.

 
  • References

  • 1 Dravet C. The core Dravet syndrome phenotype. Epilepsia 2011; 52 (Suppl. 02) 3-9
  • 2 Depienne C, Trouillard O, Saint-Martin C. , et al. Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet 2009; 46 (03) 183-191
  • 3 Brunklaus A, Zuberi SM. Dravet syndrome--from epileptic encephalopathy to channelopathy. Epilepsia 2014; 55 (07) 979-984
  • 4 Catarino CB, Liu JY, Liagkouras I. , et al. Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain 2011; 134 (Pt, 10): 2982-3010
  • 5 Steel D, Symonds JD, Zuberi SM, Brunklaus A. Dravet syndrome and its mimics: beyond SCN1A. Epilepsia 2017; 58 (11) 1807-1816
  • 6 Villas N, Meskis MA, Goodliffe S. Dravet syndrome: characteristics, comorbidities, and caregiver concerns. Epilepsy Behav 2017; 74: 81-86
  • 7 Knupp KG, Scarbro S, Wilkening G, Juarez-Colunga E, Kempe A, Dempsey A. Parental perception of comorbidities in children with Dravet syndrome. Pediatr Neurol 2017; 76: 60-65
  • 8 Lagae L, Brambilla I, Mingorance A, Gibson E, Battersby A. Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey. Dev Med Child Neurol 2018; 60 (01) 63-72
  • 9 Berkvens JJ, Veugen I, Veendrick-Meekes MJ. , et al. Autism and behavior in adult patients with Dravet syndrome (DS). Epilepsy Behav 2015; 47: 11-16
  • 10 Li BM, Liu XR, Yi YH. , et al. Autism in Dravet syndrome: prevalence, features, and relationship to the clinical characteristics of epilepsy and mental retardation. Epilepsy Behav 2011; 21 (03) 291-295
  • 11 Olivieri G, Battaglia D, Chieffo D. , et al. Cognitive-behavioral profiles in teenagers with Dravet syndrome. Brain Dev 2016; 38 (06) 554-562
  • 12 Wolff M, Cassé-Perrot C, Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia 2006; 47 (Suppl. 02) 45-48
  • 13 Caraballo RH, Fejerman N. Dravet syndrome: a study of 53 patients. Epilepsy Res 2006; 70 (Suppl. 01) S231-S238
  • 14 Brunklaus A, Ellis R, Reavey E, Forbes GH, Zuberi SM. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome. Brain 2012; 135 (Pt, 8): 2329-2336
  • 15 Brunklaus A, Dorris L, Zuberi SM. Comorbidities and predictors of health-related quality of life in Dravet syndrome. Epilepsia 2011; 52 (08) 1476-1482
  • 16 Ragona F, Granata T, Dalla Bernardina B. , et al. Cognitive development in Dravet syndrome: a retrospective, multicenter study of 26 patients. Epilepsia 2011; 52 (02) 386-392
  • 17 He N, Li BM, Li ZX. , et al. Few individuals with Lennox-Gastaut syndrome have autism spectrum disorder: a comparison with Dravet syndrome. J Neurodev Disord 2018; 10 (01) 10
  • 18 Han S, Tai C, Westenbroek RE. , et al. Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission. Nature 2012; 489 (7416): 385-390
  • 19 Maeda H, Chiyonobu T, Yoshida M. , et al. Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome. J Hum Genet 2016; 61 (06) 565-569
  • 20 Nguyen M, Roth A, Kyzar EJ. , et al. Decoding the contribution of dopaminergic genes and pathways to autism spectrum disorder (ASD). Neurochem Int 2014; 66: 15-26